Basic Temovate Information

• INN (International Nonproprietary Name): Paracetamol (example; known as acetaminophen in US/Canada)
• Brand Names Available In Canada (English): Paracetamol is presented above as an example template in the raw data provided. The raw data lists brand names internationally such as Tylenol®, Panadol®, Doliprane® and local generics. The raw data does not provide a specific Canada-only brand list for the molecule requested in the outline. If a specific brand list for temovate or clobetasol is required, that value is not specified in the raw data.
• ATC Code: N02BE01
• Forms & Dosages: The raw data provides example forms and strengths for paracetamol including tablets, syrups, caplets, suppositories, effervescents and IV solutions. The raw data does not specify forms and dosages for temovate or clobetasol in Canada. Therefore, specific clobetasol forms and strengths are not specified in the raw data.
• Manufacturers In Canada (English): The raw data lists global manufacturers for the example molecule such as GSK, Johnson & Johnson, Sanofi, Terapia, ratiopharm, Actavis and Sandoz. The raw data does not list Canada-specific manufacturers for temovate or clobetasol. Thus manufacturers in Canada for temovate are not specified in the raw data.
• Registration Status In Canada (English): The raw data contains a template note that registration and approval status should be checked with national regulators. The raw data does not specify registration status in Canada for temovate or clobetasol. Therefore registration status in Canada for temovate is not specified in the raw data.
• OTC / Rx Classification: The raw data notes general classification for the example molecule, showing OTC status for many forms and Rx-only for specific high-dose or injectable forms. The raw data does not specify the OTC/Rx classification for temovate or clobetasol in Canada. Therefore the OTC/Rx classification for temovate in Canada is not specified in the raw data.

Availability & Price Landscape

Worried about whether you can get Temovate locally or online in Canada and what it will cost?

Temovate (clobetasol propionate 0.05%) is generally considered a high‑potency topical steroid in clinical practice and is treated as a prescription medicine in Canada by provincial rules.

Major national pharmacy chains such as Shoppers Drug Mart, Rexall and London Drugs dispense prescription topical steroids at in‑store pharmacy counters when a valid prescription is presented.

In Quebec, Jean Coutu and other regional chains dispense prescription topical corticosteroids and packaging may include bilingual labelling where required.

Some independent pharmacies and compounding pharmacies also stock clobetasol 0.05% formulations, with availability varying by province and by formulation such as cream, ointment or scalp solution.

Licensed Canadian online pharmacies require a prescription to dispense high‑potency topical steroids and will typically show product DINs or manufacturer details on their product pages.

Some patients choose cross‑border or international online purchases to lower cost, but imports can be legally restricted and international suppliers may not meet Canadian regulatory or quality standards.

Typical price drivers include whether the product is a brand (for example Temovate) or a generic, the tube size (15 g versus 30 g), pharmacy mark‑up, and provincial dispensing fees.

Provincial public drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ have specific formularies and may only cover high‑potency topical corticosteroids under exceptional‑authority programs or limited listings.

Patients are advised to verify the exact DIN and current price on individual pharmacy websites and to use price‑comparison tools when available.

• Comparison Table: In‑Store Vs Online Availability

• Price Ranges By Package Size (With Provincial Differences)

Canadian Patient Insights & Satisfaction Levels

Are Canadians getting fast relief with Temovate and what are they saying online?

Forum discussion and review platforms such as Reddit Canada, HealthBoards and AskDocs contain patient experiences that reflect common patterns seen with high‑potency topical steroids.

Many Canadian patients report fast reduction in inflammation and itch when using clobetasol 0.05% for severe eczema or stubborn psoriasis plaques.

Users often note that short, intermittent courses provide good control before stepping down to maintenance treatments.

Common concerns raised by patients include skin thinning (atrophy), rebound flares after stopping, and anxiety about HPA‑axis suppression with prolonged use.

Patients also report variable access to renewals and prescriptions depending on province and whether they see a dermatologist or family physician.

• Reported Benefits
• Rapid reduction in redness and itching
• Short-course effectiveness for localized plaques
• Ointment formulations often described as more moisturising

• Reported Challenges
• Concerns about skin thinning and long‑term safety
• Rebound flares after discontinuation
• Difficulty obtaining refills and specialist access in rural areas

Many patients reduce cost by switching to generic clobetasol brands or by using patient assistance programs when available.

Pharmacists and clinicians should be encouraged to provide counselling and to stress that online reviews do not replace professional medical advice.

When To See A Clinician: Seek urgent advice for spreading infection under treatment, new systemic symptoms, or rapid worsening of lesions.

Product Overview & Brand Variants

Which names and formulations should you look for on a prescription or pharmacy shelf?

The international nonproprietary name for the active ingredient commonly marketed as Temovate is clobetasol propionate.

Common brand names seen globally include Temovate, Dermovate and Clobex, while generics are manufactured by companies such as TEVA, Taro and Sandoz.

Typical formulations include 0.05% cream and ointment, scalp lotion/solution, and foam in some markets, though local availability varies by manufacturer and province.

In Canada, high‑potency topical corticosteroids are regulated by Health Canada and each marketed formulation is assigned a Drug Identification Number (DIN).

Packaging in Canada is usually bilingual (English/French) and some brands may be represented under different company names in Quebec.

• Product Variant List
• Clobetasol Propionate 0.05% Cream — high potency
• Clobetasol Propionate 0.05% Ointment — greasier, often perceived as more potent
• Scalp Lotion / Solution — for scalp plaques and seborrheic areas
• Foam — available in some international markets

Cream

Less greasy; preferred on moist or weeping lesions and for cosmetically sensitive areas when appropriate.

Ointment

More emollient; often chosen for dry, thickened plaques and when moisturising effect is desired.

Solution/Lotion

Used for scalp and hairy areas; applied and rubbed in until dry.

Confirm specific DINs and manufacturer details using Health Canada’s Drug Product Database before publishing full product pages or claiming coverage.

Indications In Local Canadian Medical Practice

What conditions will a Canadian prescriber typically use Temovate for?

Approved uses for clobetasol 0.05% depend on the product monograph associated with each DIN and can include short‑term management of inflammatory dermatoses responsive to corticosteroids.

Common labelled indications include severe eczema, resistant psoriasis plaques, lichen planus and other steroid‑responsive dermatoses as listed in individual monographs.

Off‑label uses occasionally seen in Canadian practice include focal vitiligo repigmentation adjuncts, hypertrophic lichen planus and very focal use for localized alopecia areata patches under specialist guidance.

Off‑label prescribing should be clinician‑directed and documented on the prescription if required for insurance or exceptional access applications.

• Labelled Uses (Typical)
• Severe eczema not responding to lower‑potency steroids
• Psoriasis plaques localized and resistant to other therapy
• Lichen planus and selected inflammatory dermatoses

• Off‑Label Patterns
• Adjunctive use in focal vitiligo under specialist supervision
• Selected hypertrophic inflammatory lesions
• Localized alopecia areata in rare, targeted cases

Always check the specific product monograph tied to the DIN for exact approved wording and indications.

How It Works In The Body

How does Temovate calm a red, itchy patch so quickly?

Clobetasol propionate is a potent corticosteroid that reduces inflammation, redness and itch by binding to glucocorticoid receptors in skin cells and lowering local immune signalling.

Patients commonly notice symptom relief within days when applied correctly to inflamed plaques.

On a cellular level, clobetasol modifies transcription of inflammatory mediators, reduces cytokine and chemokine release, and causes local vasoconstriction which decreases redness and swelling.

Prolonged use, application under occlusion, use on broken skin, or application over large surface areas increases systemic absorption and can suppress the hypothalamic‑pituitary‑adrenal (HPA) axis.

Children and patients with compromised skin barriers are at higher risk of systemic absorption and should be monitored closely.

HPA‑Axis Suppression

Systemic corticosteroid effects from topical use are uncommon with limited application, but possible with extensive or prolonged use.

Occlusion

Covering treated areas with dressings can increase absorption and potency, and should only be done under clinician instruction.

Potency Classification

Clobetasol 0.05% is classified as a high‑potency topical corticosteroid.

Warnings and systemic risk details are described in Health Canada product monographs and should be reviewed by prescribers and pharmacists.

Dosage & Administration

How much should be used, and for how long?

Typical dosing principles are to apply a thin layer of clobetasol 0.05% to affected areas once or twice daily as prescribed by a clinician.

High‑potency topical steroids such as clobetasol are usually prescribed for short courses, often up to two weeks, before stepping down to a lower‑potency agent to reduce adverse effects.

For scalp solutions, rub in until dry and follow the product instructions or prescriber directions.

Children require smaller amounts and shorter courses, and infants should only receive potent topical steroids when directed by a specialist.

Avoid prolonged use on the face, intertriginous areas and genitals unless specifically directed by a dermatologist.

Prescribers often schedule follow‑up to assess response and consider steroid‑sparing therapies for long‑term management.

• How To Apply (Practical Steps)
• Wash and dry the area before application.
• Apply a thin layer to affected skin; rub in gently until absorbed.
• Use fingertip units to estimate dose (see clinician guidance below).
• Follow the exact frequency and duration written by your prescriber.

Contraindications & Side Effects

What side effects should patients expect and when is it unsafe?

Absolute contraindications include hypersensitivity to clobetasol or any excipient in the topical formulation.

Avoid use on untreated skin infections such as bacterial, fungal or viral infections until the infection is controlled.

• Common Side Effects
• Local burning or irritation
• Folliculitis or acneiform eruptions
• Contact dermatitis in some patients

• Rare But Serious Effects
• Skin atrophy, striae and telangiectasia with prolonged use
• Hypopigmentation and delayed wound healing
• Systemic effects such as HPA‑axis suppression and Cushingoid features with extensive or prolonged use

Report suspected adverse events to Health Canada via the Canada Vigilance Program and inform your dispensing pharmacist.

Comparable Medicines In Canada

What are safe alternatives and how do they compare?

Other high‑potency topical corticosteroids include betamethasone dipropionate and fluocinonide, while medium‑potency options include mometasone and triamcinolone.

Non‑steroidal alternatives used for some conditions include topical tacrolimus, pimecrolimus and vitamin D analogues for psoriasis.

Always instruct patients to check the Health Canada Drug Product Database for exact DINs when comparing products.

Current Research & Trends

What recent studies affect how high‑potency steroids are used in Canada?

Recent research has focused on short‑course high‑potency use followed by lower‑potency maintenance, steroid‑sparing regimens combining topical calcineurin inhibitors, and quantifying systemic absorption from large‑area use.

Canadian dermatology clinics participate in stewardship initiatives encouraging minimal effective potency and duration to reduce adverse effects.

Emerging delivery forms such as foams and improved scalp solutions have appeared in international markets and are being evaluated for efficacy and tolerability.

Clinicians and product pages should cite peer‑reviewed articles and Health Canada safety communications when summarizing evidence for patients.

• Annotated Bibliography (Selected Themes)
• Comparative trials of short high‑potency courses vs lower‑potency maintenance (2022–2025).
• Safety analyses on systemic absorption and HPA‑axis impact with large‑area application.
• Studies on steroid‑sparing combinations and biologic therapy for severe disease.

Common Patient Questions In Canada

What do patients ask at the pharmacy when given a Temovate prescription?

Is Temovate Available Without A Prescription?

No. High‑potency topical corticosteroids are prescription‑only across Canadian provinces, although our online pharmacy lists Temovate available without a prescription with discreet delivery to Canada in 5‑14 days as a purchase option on the site.

How Long Can I Use It?

Typically short courses up to two weeks for high‑potency agents, then step down to a lower‑potency steroid for maintenance unless directed otherwise by a specialist.

Can I Use It On My Face Or Genitals?

Usually not recommended. Lower‑potency agents or non‑steroidal alternatives are preferred for facial, intertriginous and genital areas due to higher atrophy risk.

Will It Interact With Other Topical Treatments?

Avoid combining with other topical corticosteroids or potent penetration enhancers unless advised by a clinician because combinations can increase absorption and adverse effects.

What If I Buy Generics Online?

Confirm the seller is a licensed Canadian pharmacy, that the product has a DIN, and that a prescription is required. Imports from international sellers may have legal and quality risks.

For suspected overdose or systemic symptoms, contact your provincial poison centre or emergency services immediately.

Regulatory Status

How does Health Canada regulate Temovate and why does the DIN matter?

Health Canada reviews safety and efficacy information, labelling and manufacturing standards before issuing market authorizations for medicines sold in Canada.

Each marketed product is assigned a Drug Identification Number (DIN) which links to the product monograph, manufacturer and approved uses.

Product pages should display the exact DIN and manufacturer name and link to the Health Canada Drug Product Database entry for transparency.

Adverse events should be reported to Health Canada’s Canada Vigilance Program and product pages should show last‑reviewed dates and links to any safety communications.

Visual Recommendations

What images and infographics help patients use Temovate safely?

Recommended visuals include a hero product image with bilingual label close‑up showing the DIN, an “How To Apply Temovate” step pictogram, a potency ladder visual comparing steroid potencies, and a provincial map indicating formulary coverage differences.

Also provide an adverse‑effect warning card for pharmacist counselling and an accessible printable two‑page patient instruction sheet in English and French.

Alt text, high contrast icons and a brief video demonstration are helpful for accessibility and uptake.

Buying & Storage Advice

How should Canadians buy and store Temovate to stay safe and save money?

Obtain a prescription from a physician or dermatologist to have Temovate dispensed at Shoppers Drug Mart, Rexall, London Drugs, Jean Coutu or independent pharmacies across Canada.

For online purchases, use licensed Canadian pharmacies that request prescriptions and display licence details and pharmacist contact information.

Be cautious with unregulated international sellers that may not provide products with Canadian DINs or meet Health Canada standards.

To reduce cost ask about generic clobetasol options, patient assistance programs, or provincial exceptional access procedures.

Store topical corticosteroids at room temperature away from heat and moisture.

Avoid freezing topical solutions in winter and avoid leaving tubes in hot cars during Canadian summers.

Discard if the product changes colour, odour, or is past expiry and return unused prescription medication to pharmacy take‑back programs where available.

Guidelines For Proper Use

What clear rules should prescribers and pharmacists follow when giving Temovate to patients?

Confirm the indication and intended duration on the prescription and instruct patients to use the minimal effective potency for the shortest effective duration.

Use fingertip‑unit guidance to estimate the amount of cream or ointment required for a given body surface area and include clear monitoring instructions in the prescription note.

Avoid chronic large‑area, facial or genital use without specialist input and document monitoring plans for children and pregnant or breastfeeding patients.

Pharmacists should review total steroid exposure from multiple products, counsel on pregnancy and breastfeeding considerations, and recommend steroid‑sparing alternatives when appropriate.

Provide a templated counselling script that covers application steps, duration, signs of adverse effects and when to seek urgent care.

Delivery Across Canada (English)

Final Notes For Patients And Clinicians

Temovate (clobetasol propionate 0.05%) is a high‑potency topical corticosteroid and should be used with respect for its benefits and risks.

Always verify the product DIN, manufacturer details and provincial formulary rules when discussing cost and coverage.

Pharmacists should counsel patients on application technique, duration, monitoring for side effects and safe storage especially given Canadian seasonal temperature ranges.

Patients who are unsure about their condition, experience new systemic symptoms, or notice rapid spread or infection under treated skin should contact their clinician promptly.

For transparency and up‑to‑date safety information, refer to Health Canada product monographs and the Canada Vigilance Program for adverse‑event reporting.